Short answer
Enpro Inc. (NPO) filed its fiscal 2025 10-K annual report with the SEC on Feb 19, 2026. It reported revenue of $1.1B (+9.0% year over year) and net income of $41M.
- Top risk flagged: Regulatory risk from higher effective tax rate 29.6% in 2025 vs 22.8% in 2024 due to foreign jurisdiction tax rates impacting net $3.7 million expense
FY2025 key financial metrics · XBRL
- Revenue
- $1.1B
- +9.0% YoY
- Net income
- $41M
- −44.4% YoY
- Operating margin
- 14.1%
- +0.6 pp YoY
- Gross margin
- 42.6%
- +0.2 pp YoY
- EPS (diluted)
- $1.91
- −44.6% YoY
- ROE
- 2.6%
- −2.5 pp YoY
- Operating cash flow
- $201M
- +23.5% YoY
Source: XBRL data from the Enpro Inc. (NPO) FY2025 10-K on SEC EDGAR. USD.
Enpro Inc. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: Industrial technology company providing proprietary products for critical applications across diverse growing end markets including semiconductor and life sciences
- New acquisitions in 2025: Overlook Industries ($273.9M) for single-use biopharmaceutical tech, and AlpHa Measurement ($273.9M) for liquid analytical sensing technologies
- Strategic shift: Expanded Sealing Technologies segment with acquisitions focused on process monitoring and biopharmaceutical production
- Revenue growth to $1.143B in 2025, up from $1.049B in 2024, driven by U.S. sales increasing from $602M to $647M
- Full ownership acquired of Alluxa subsidiary in 2024 via $17.9M purchase of non-controlling interests, consolidating control without change in company control
Management Discussion & Analysis
- Operating cash flow $201.2M in 2025 vs $162.9M in 2024 and $208.4M in 2023, increase driven by revenue and operating income growth
- Investing cash use $316.9M in 2025 including $273.9M acquisitions and $42.0M capex, up from $241.5M in 2024 and $7.4M in 2023
- Financing cash used $17.4M in 2025; dividends $26.2M; issued $450M Senior Notes at 6.125%, repaid $350M 5.75% Senior Notes
- Dividends increased to $0.31/share in 2025 and $0.32/share in 2026; share repurchase program authorized up to $50M starting Oct 2024
- No goodwill impairment in 2025; largest impairment $60.8M in 2023 related to Alluxa; semiconductor segment fair value > carrying value as of Nov 2025
Risk Factors
- Regulatory risk from higher effective tax rate 29.6% in 2025 vs 22.8% in 2024 due to foreign jurisdiction tax rates impacting net $3.7 million expense
- Geopolitical exposure via 15 manufacturing facilities in 8 countries, including adverse foreign exchange impacts of $3.4 million sales and $3.7 million costs in 2025
- Operational vulnerability from rising material costs and mix headwinds reducing Segment AEBITDA by $3.8 million in Sealing Technologies in 2025
- Competitive threat from semiconductor market volatility impacting Advanced Surface Technologies’ sales, with 13.6% growth driven by choppy semiconductor capital equipment demand
- Financial risk from $67.2 million noncash pension settlement loss in Q4 2025 following U.S. defined benefit pension plan termination
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.